This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Pharmafox Therapeutics Ag. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Marina Maria Boido: Innovator in Muscle Performance Improvement
Introduction
Marina Maria Boido is a notable inventor based in Nichelino, Italy. She has made significant contributions to the field of neuromuscular treatments through her innovative research and development of compounds aimed at improving muscle performance.
Latest Patents
Marina holds a patent for "Muscle performance improvement compounds comprising C-terminus agrin fragment and an ACTR2B inhibitor." This patent describes a compound that includes at least two components: a first component being the nLG3 or (h)nLG3 domain from the C-terminus of mouse or human agrin, and at least one second component selected from proteins or an antagonistic antibody that inhibits ActR2B-induced signaling activity in the presence of myostatin. These compounds are designed to be effective treatments for neuromuscular diseases and related issues. She has 1 patent to her name.
Career Highlights
Marina is currently associated with Pharmafox Therapeutics AG, where she continues her research and development efforts. Her work focuses on creating innovative solutions for muscle performance enhancement, which has the potential to significantly impact the treatment of neuromuscular disorders.
Collaborations
Marina collaborates with esteemed colleagues such as Jan Willem Vrijbloed and Olena Butenko, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Marina Maria Boido is a pioneering inventor whose work in muscle performance improvement compounds showcases her commitment to advancing medical science. Her contributions are vital in the ongoing fight against neuromuscular diseases, and her innovative spirit continues to inspire others in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile